drugset / Trial / NCT00549549
Celebrex In Acute Gouty Arthritis Study
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multicenter, double-blind, double-dummy, randomized, active-controlled study that will include an 8-day treatment period followed by a 1-week follow-up period in patients experiencing symptoms of an acute exacerbation of gouty arthritis.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 50 mg | — |
| Subject | Celecoxib | Other / unclassified | 200 mg | — |
| Subject | Celecoxib | Other / unclassified | 400 mg | — |
| Comparator | Indomethacin | Small molecule | 50 mg | — |